Several studies that aim to characterize and quantify the release and composition, particle size, and residence time in the indoor environment will be presented in the Exposure and Risk Assessment of 3D Printing and Emerging Materials symposium on December 15, from 12:00-1:30 p.m. ET at the 2020 Society for Risk Analysis virtual Annual Meeting held December 13-17, 2020.
National efforts to develop a coronavirus disease 2019 (COVID-19) vaccine at 'warp speed' will likely yield a safe and effective vaccine by early 2021. However, this important milestone is only the first step in an equally important challenge: getting a majority of the U.S. public vaccinated.
A multi-institutional study finds that COVID-19 can be found in post-mortem corneal tissue, highlighting the importance of the donor screening process.
As the world watches how UK residents respond to COVID-19 vaccinations, three leading experts on the virus are urging Americans and the US government to be vigilant against anti-vaccination advocates and their 'rumors, misinformation, and conspiracy theories in a fractured media universe.'
This Viewpoint discusses the need for scientific rigor in studies related to COVID-19 and presents study design recommendations and methodologies that should be incorporated to ensure that findings are reliable and reproducible.
A diagnostic study, this describes an online tool created with actual SARS-CoV-2 virus copy number data to help policy makers understand how pooled testing compares with single-sample testing in different populations.
Wits University scientists were amongst the co-authors who published the first peer-reviewed results of phase 3 human trials of the Oxford/AstraZeneca Covid-19 vaccine, in prestigious scientific journal The Lancet, on 8 December. Wits leads the SA leg of the Oxford Covid-19 vaccine trials.
A decade after the birth of the first primates born with the aid of a gene therapy technique designed to prevent inherited mitochondrial disease, a careful study of the monkeys and their offspring reveals no adverse health effects. The new study generally bolsters the scientific basis for mitochondrial replacement therapy in human clinical trials, with an important caveat: Researchers found varying levels of carryover maternal mitochondrial DNA that had preferentially replicated and accumulated within some internal organs, although not enough to cause health effects.
Regulated medical device reprocessing is an important tool in improving environmental and public health outcomes, according to a new analysis published in Health Affairs. The paper indicates that health care systems generate significant amounts of air pollution and greenhouse gas emissions, the majority of which come from the supply chain. Hospitals that have medical devices reprocessed by regulated reprocessors removed over 7,100 tons of waste, a number that could grow dramatically, according to the researchers.
Ikerbasque Research Professor Iñigo de Miguel Beriain, who works with the UPV/EHU Chair in Law and the Human Genome, defends the usefulness of immunity passports, providing they are used to protect the rights of those who are immune. He also warns that vaccine distribution will create similar problems related to immunity-based licenses.